Plasma EVs are potential biomarkers of DMD, as a set of muscle-enriched miRNAs, named myomiRs (miR-1, miR-133, and miR-206), are highly elevated in the serum of patients with DMD and in dystrophin-deficient animal models. Here, DMD is linked to Duchenne muscular dystrophy.